Clinical significance of the ADVANCE study for a practitioner: Possibility to treat and prevent complications of type 2 diabetes mellitus
https://doi.org/10.14341/probl20095556-9
Abstract
ADVANCE is a multicentre placebo-controlled randomized trial undertaken to investigate effects of intensive decrease of blood pressure and blood glucose level on the development of major micro- and macrovascular complications in patients with type 2 diabetes mellitus. Patients included in the study designed to evaluate results of intense glycemic control were given glyclazide modified release (diabeton MR) as the basic treatment. The main results of ADVANCE indicate that intense hypoglycemic therapy with the use of diabeton MR allows for efficient and safe control of blood glucose level with the reduction of the mean HbA1c level to 6.5% or less. Also, this treatment significantly decreases the risk of severe diabetic complications by 10% including nephropathy and proteinuria (by 21% and 30% respectively).
About the Author
V N ShishkovaState Research Centre of Preventive Medicine, Federal Agency for High Medical Technologies
Russian Federation
References
1. Дедов И. И., Ремизов О. В., Петеркова В. А. // Сахарный диабет. - 2001. - № 4. - С. 26-31.
2. Дедов И. И., Шестакова М. В. Сахарный диабет и артериальная гипертензия. - М., 2006. - С. 344
3. The Action to Control Cardiovascular Risk in Diabetes Study Group // N. Engl. J. Med. - 2008. - Vol. 358. - P. 2545- 2559.
4. ADVANCE Collaborative Group // Diabet. Metab. - 2003. - Vol. 29. - P. 47-48
5. ADVANCE Collaborative Group // N. Engl. J. Med. - 2008. - Vol. 358. - P. 2560-2572.
6. Bak J., Schmitz O., Niels S. et al. // Diabetes. - 1989. - Vol. 38. - P. 1343-1350.
7. Bruttomesso D., Pianta A., Veiro A. et al. // Diabetes. - 1999. - Vol. 48. - P. 99-105.
8. Chalmers J. et al. // Diabetologia. - 2001. - Vol. 44. - P. 1118-1120.
9. Droin P. and the Diamicron MR Study Group // J. Diabet. Complications. - 2000. - Vol. 14. - P. 185-191.
10. Gregorio F., Ambrosi F., Cristallini S. et al. // Diabet. Res. Clin. Prac. - 1992. - Vol. 18. - P. 197-206.
11. Francillard M., Frey N., Paraire M. et al. // J. Nutr. Hlth Aging. - 2001. - Vol. 5 (Special Issue). - P. 14.
12. Johnson A., Argyraki M., Thow Ir. et al. // Diabet Med. - 1991. - Vol. 8. - P. 243-253.
13. Nathan D. M. et al. // Diabetes Care. - 2008. - Vol. 31, N 12.
14. O'Brien R. C., Luo M., Balaz N. et al. // J. Diabet. Complications. - 2000. - Vol. 14. - P. 201-206.
15. Riccio A., Lisato G., Vigili de Kreutzenberg S. et al. // Metabolism. - 1996. - Vol. 45. - P. 1196-1202.
16. Schernthaner G., Di Vario U., Grimaldi A. // Diabetologia. - 2003. - Vol. 46. - Suppl. 2. - P. A28.
17. Steven E., Kahn C. // J. Clin. Endocrinol. Metab. - 2001. - Vol. 86, N 9. - P. 4047-4058.
18. The UKPDS Group // Diabetes. - 1995, - Vol. 44. - P. 1249-1258.
19. Wallace T. M., Matthews D. R. // Textbook of Diabetes: Selected Chapters / Eds J. C. Pickup et al. - 3-rd Ed. - Oxford, 2005. - P. 15-18.
20. Wild S., Roglic G. et al. // Diabetes Care. - 2004. - Vol. 27. - P. 1047-1053.
Review
For citations:
Shishkova V.N. Clinical significance of the ADVANCE study for a practitioner: Possibility to treat and prevent complications of type 2 diabetes mellitus. Problems of Endocrinology. 2009;55(5):6-9. (In Russ.) https://doi.org/10.14341/probl20095556-9
Views:
1920
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
